Welcome to our dedicated page for Cochlear Ord Adr news (Ticker: CHEOY), a resource for investors and traders seeking the latest updates and insights on Cochlear Ord Adr stock.
Cochlear (CHEOY) reports developments in implantable hearing solutions for people with hearing loss. Company news centers on the Nucleus cochlear implant portfolio, including the Nucleus Nexa System, Kanso and Nucleus sound processors, and on bone conduction products such as the Baha Sound Processor, Baha SoundBand and Osia System.
Recurring updates cover U.S. FDA approvals, commercial product releases, Bluetooth LE Audio and streaming features, rechargeable battery and processor design changes, fitting software, recipient support and Connected Care services. Cochlear news also includes hearing health advocacy, Medicare coverage context, scholarships for device recipients, customer support technology and recognition within healthcare and medical technology categories.
Cochlear welcomes the WHO's first World Report on Hearing, launched on March 3, 2021, which calls for prioritizing hearing health globally. The report highlights that 1.5 billion people experience some degree of hearing loss, with around 60 million facing severe to complete loss. It emphasizes the effectiveness and cost-effectiveness of cochlear implants and urges member states to integrate hearing care into primary health systems. Cochlear's CEO, Dig Howitt, stresses the need for urgent action to tackle the rising prevalence of hearing loss, supported by prominent advocates like Malala Yousafzai.
Cochlear Limited (ASX: COH) announced the winners of the 2021 Graeme Clark and Anders Tjellström Scholarships, recognizing eight exemplary Cochlear™ Nucleus® Implant, Baha® System, and Osia® System recipients from the U.S. and Canada. Each winner will receive $2,000 per year for up to four years, totaling $64,000 in scholarships for this year alone. Since 2002, the company has awarded $824,000 to 112 students. The scholarships aim to support Cochlear recipients in achieving their educational and career goals while promoting leadership in the hearing loss community.
Cochlear Limited (ASX: COH) launched the Hearing 20/20 campaign during Audiology Awareness Month to promote a common metric for normal hearing: 20 decibels in each ear. Supported by ten partners, this initiative aims to emphasize the significance of hearing health, especially for adults aged 55 and older. The campaign highlights that the third most common chronic condition, hearing loss, impacts many, yet only 9% of consumers know its definition. Cochlear encourages annual hearing tests and discussions regarding hearing health with primary care providers.
Cochlear Limited (ASX: COH) has introduced the Cochlear Hearing Aid Check, a new online tool aimed at helping adults with hearing loss determine if they could benefit from a cochlear implant. During Healthy Aging Month, this free tool provides comparative insights between hearing aids and cochlear implants. Notably, research indicates that a significant portion of adults over 50 years old perform poorly with hearing aids. With an increasing prevalence of hearing loss among older adults, this initiative aims to improve awareness and access to effective solutions like cochlear implants.